Screener
Integra LifeSciences IART Short-term borrowings under securitization facility
Short-term borrowings under securitization facility at other companies
Other financials
Where this comes from
Reported directly by Integra LifeSciences in its filing.
Tagged under the XBRL concept iart:SecuredDebtSecuritizationProgramCurrent.
The source filing: Integra LifeSciences’s 10-K, filed February 26, 2026.
- Filed
- Feb 26, 2026, 4:02 PM EST
- Fiscal year
- FY2025
- Accession
- 0000917520-26-000011
| (Dollars in thousands, except per share amounts) | December 31, 2025 | December 31, 2024 |
|---|---|---|
| LIABILITIES AND STOCKHOLDERS’ EQUITY | ||
| Current liabilities: | ||
| Current portion of borrowings under senior credit facility | $38,750 | $33,906 |
| Short-term borrowings under securitization facility | 87,800 | — |
| Current portion of lease liability - operating leases | 14,019 | 14,540 |
| Convertible securities | — | 573,170 |
| Accounts payable, trade | 95,726 | 82,502 |
| Contract liabilities | 11,463 | 10,483 |
ITEM 16. FORM 10-K SUMMARY
FAQ
- What is Integra LifeSciences's short-term borrowings under securitization facility?
- Integra LifeSciences (IART) reported short-term borrowings under securitization facility of $87.8M in Q4 2025.
- What does short-term borrowings under securitization facility mean?
- This represents the short-term portion of debt obligations financed through a securitization facility, where specific assets are pledged as collateral. It reflects the company's reliance on asset-backed financing to manage working capital and short-term funding needs. Investors track this to understand the company's dependency on specialized credit facilities and the potential impact of asset performance on liquidity.
Ask your AI about Integra LifeSciences's short-term borrowings under securitization facility.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude